Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $46.6000 (-3.08%) ($45.8000 - $48.0000) on Wed. Nov. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.19% (three month average) | RSI | 40 | Latest Price | $46.6000(-3.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.1% a day on average for past five trading days. | Weekly Trend | BAX declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(51%) SPY(49%) IVE(48%) | Factors Impacting BAX price | BAX will decline at least -0.595% in a week (0% probabilities). TLT(-17%) VIXM(-16%) GDXJ(-9%) UUP(-5%) TIP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.595% (StdDev 1.19%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
Resistance Level | $47.54 | 5 Day Moving Average | $47.23(-1.33%) | 10 Day Moving Average | $47.15(-1.17%) | 20 Day Moving Average | $47.54(-1.98%) | To recent high | -5.2% | To recent low | 3.3% | Market Cap | $23.774b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |